All In Biotech

Drug Trial Radar · NCT06144840

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria

Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 165 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

165

Actual

Start

Dec 11, 2023

Primary completion

Apr 14, 2026

Study completion May 19, 2026

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Nov 22, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.

Conditions

  • Erythropoietic Protoporphyria (EPP)
  • X-Linked Protoporphyria (XLP)

Interventions

  • DersimelagonDrug

    MT-7117

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in average daily sunlight exposure time (minutes) to first prodromal symptom (burning, tingling, itching, or stinging) associated with sunlight exposure between 1 hour post-sunrise and 1 hour pre-sunset at Week 16Time frame: Week 16

Locations

35 sites in 11 countries. Site status is shown where the registry gives one.

  • Marvel Clinical Research, LLC

    Huntington Beach, California

  • University of California at San Francisco

    San Francisco, California

  • University Of Miami School Of Medicine, Center For Liver Diseases

    Miami, Florida

  • MGH

    Boston, Massachusetts

  • MetroBoston Clinical Partners, LLC

    Brighton, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Kansas City Research Institute

    Kansas City, Missouri

  • Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH)

    New York, New York

  • Wake Forest University Baptist Health

    Winston-Salem, North Carolina

  • Remington-Davis Clinical Research

    Columbus, Ohio

  • Einstein Medical Center (EMC)

    Philadelphia, Pennsylvania

  • The University of Texas Medical Branch (UTMB)

    Galveston, Texas

  • University of Washington

    Seattle, Washington

  • Royal Melbourne Hospital (RMH)

    Parkville, Victoria, Australia

  • University Multi-Profile Hospital for Active Treatment (UMHAT) St. Ivan Rilski - Porphyria Center

    Sofia, Bulgaria

  • Institute for Clinical and Experimental Medicine - IKEM

    Prague, Czechia

  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre

    Bordeaux, France

  • CHU Nantes

    Nantes, France

  • Hôpital Bichat - Hospital Bichat-Hopitaux Universitaires Paris Nord Val de Seine

    Paris, France

  • Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Louis-Mourier

    Paris, France

  • Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia

    Brescia, Italy

  • Azienda Sanitaria Ospedaliera Santa Croce E Carle - Cuneo

    Cuneo, Italy

  • Ospedalle Galliera

    Genova, Italy

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano

    Milan, Italy

  • U.O.C. Medicina Interna Azienda ospedaliero Universitaria Policlinico di Modena

    Modena, Italy

  • IFO-San Gallicano IRCCS

    Rome, Italy

  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Materno-Infantile - Burlo Garofolo - Clinica Pediatrica

    Trieste, Italy

  • Tokyo Saiseikai Central Hospital

    Tokyo, Japan

  • Mazda Hospital

    Aki-gun, Hiroshima, Japan

  • Hamamatsu University Hospital

    Hamamatsu, Shizuoka, Japan

  • Universitair Medisch Centrum Rotterdam

    Rotterdam, Netherlands

  • Instytut Hematologii I Transfuzjologii

    Warsaw, Poland

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital General Universitario De Valencia

    Valencia, Spain

  • Guy's Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.